Strs Ohio Takes $6.92 Million Position in CBIZ, Inc. $CBZ

Strs Ohio purchased a new stake in shares of CBIZ, Inc. (NYSE:CBZ) during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 91,200 shares of the business services provider’s stock, valued at approximately $6,918,000. Strs Ohio owned approximately 0.17% of CBIZ at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the stock. Vestcor Inc increased its stake in CBIZ by 5.3% during the 1st quarter. Vestcor Inc now owns 2,922 shares of the business services provider’s stock valued at $222,000 after purchasing an additional 148 shares in the last quarter. Assetmark Inc. increased its stake in CBIZ by 19.9% during the 1st quarter. Assetmark Inc. now owns 905 shares of the business services provider’s stock valued at $69,000 after purchasing an additional 150 shares in the last quarter. Xponance Inc. increased its stake in CBIZ by 5.7% during the 1st quarter. Xponance Inc. now owns 3,620 shares of the business services provider’s stock valued at $275,000 after purchasing an additional 195 shares in the last quarter. Avantax Advisory Services Inc. increased its stake in CBIZ by 4.4% during the 1st quarter. Avantax Advisory Services Inc. now owns 4,956 shares of the business services provider’s stock valued at $376,000 after purchasing an additional 209 shares in the last quarter. Finally, Principal Financial Group Inc. increased its stake in CBIZ by 0.8% during the 1st quarter. Principal Financial Group Inc. now owns 31,766 shares of the business services provider’s stock valued at $2,410,000 after purchasing an additional 243 shares in the last quarter. Institutional investors and hedge funds own 87.44% of the company’s stock.

CBIZ Trading Down 3.7%

CBZ stock opened at $55.79 on Monday. The company’s 50-day simple moving average is $66.59 and its 200-day simple moving average is $70.49. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 0.79. CBIZ, Inc. has a 52-week low of $55.59 and a 52-week high of $90.13. The firm has a market cap of $3.01 billion, a P/E ratio of 32.06 and a beta of 0.95.

CBIZ (NYSE:CBZ) last posted its earnings results on Wednesday, July 30th. The business services provider reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.84 by $0.11. CBIZ had a net margin of 4.51% and a return on equity of 14.73%. The business had revenue of $683.50 million for the quarter, compared to analyst estimates of $701.43 million. During the same period in the prior year, the company posted $0.39 EPS. The company’s revenue for the quarter was up 62.7% on a year-over-year basis. CBIZ has set its FY 2025 guidance at 3.600-3.650 EPS. As a group, equities analysts forecast that CBIZ, Inc. will post 2.65 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, William Blair restated an “outperform” rating on shares of CBIZ in a research note on Friday, September 5th. One research analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the stock has an average rating of “Buy”.

Insider Activity

In other news, Director Rodney A. Young bought 2,000 shares of the stock in a transaction dated Friday, August 8th. The shares were acquired at an average cost of $62.43 per share, with a total value of $124,860.00. Following the purchase, the director directly owned 8,310 shares in the company, valued at $518,793.30. The trade was a 31.70% increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 4.95% of the stock is currently owned by insiders.

About CBIZ

CBIZ, Inc provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. The Financial Services segment offers accounting and tax, financial advisory, valuation, risk and advisory, and government healthcare consulting services.